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Abstract
Background: In the present study, a technique for com-
puter-assisted, normothermic, oxygenated, ex vivo, re-
circulating small bowel perfusion was established as a
tool to investigate organ pretreatment protocols and
ischemia/reperfusion phenomena. A prerequisite for the
desired setup was an organ chamber for ex vivo perfu-
sion and the use of syngeneic whole blood as perfusate.
Methods: The entire small bowel was harvested from
Lewis rats and perfused in an organ chamber ex vivo for
at least 2 h. The temperature was kept at 37°C in a water
bath. Three experimental groups were explored, charac-
terized by different perfusion solutions. The basic perfu-
sate consisted of syngeneic whole blood diluted with
either NaCl, Krebs’ solution or Krebs’ solution and nor-
epinephrine to a hematocrit of 30%. In addition, in each
group l-glutamine was administered intraluminally. The
desired perfusion pressure was 100 mm Hg which was
kept constant with a computer-assisted data acquisition
software, which measured on-line pressure, oxygena-
tion, flow, temperature and pH and adjusted the pressure
by changing the flow via a peristaltic pump. The viability
of the preparation was tested by measuring oxygen con-
sumption and maltose absorption, which requires intact
enzymes of the mucosal brush border to break down
maltose into glucose. Results: Organ perfusion in
group 1 (dilution with NaCl) revealed problems such as
hypersecretion into the bowel lumen, low vascular resis-
tance and no maltose uptake. In contrast a viable organ
could be demonstrated using Krebs’ solution as dilution
solution. The addition of norepinephrine led to an im-
proved perfusion over the entire perfusion period. Malt-
ose absorption was comparable to tests conducted with
native small bowel. Oxygen consumption was stable
during the 2-hour perfusion period. Conclusions: The ex
vivo perfusion system established enables small bowel
perfusion for at least 2 h. The viability of the graft could
be demonstrated. The perfusion time achieved is suffi-
cient to study leukocyte/lymphocyte interaction with the
endothelium of the graft vessels. In addition, a viable
small bowel, after 2 h of ex vivo perfusion, facilitates
testing of pretreatment protocols for the reduction of the
immunogenicity of small bowel allografts.
Copyright © 2000 S. Karger AG, Basel
Computer-Assisted ex vivo, Normothermic
Small Bowel Perfusion
Eur Surg Res 2000;32:100–106 101
Fig. 1. Perfusion system.
Introduction
Small bowel transplantation (SBT) still lacks the suc-
cess rates of liver, heart or kidney transplantation. De-
spite the success of new immunosuppressive agents, e.g.
tacrolimus or mycophenolic acid, in other solid organ
transplantation, 2-year graft survival after allogeneic SBT
in adults is only 38% [1]. Increasing immunosuppression,
by adding supplementary agents (e.g. antibodies) to the
medication of the recipient, will increase the risk of septic
complications [2]. New strategies are necessary to im-
prove the clinical results of SBT. Among these are proto-
cols for local immunosuppression [3] and graft pretreat-
ment [4]. In order to test strategies for the modulation of
small bowel immunogenicity, we have established a com-
puter-assisted ex vivo small bowel perfusion model which
enables a normothermic, pressure-controlled perfusion
for at least 2 h. A variety of experiments carried out in the
60s and 70s showed that special additives and perfusion
solutions are required to meet the need of the intestinal
epithelium [5, 6]. Three different types of perfusion solu-
tions and additives were tested in our experiments. In
each case, the blood was diluted to a hematocrit of 30%.
In group 1 (n = 14) NaCl, in group 2 (n = 11) Krebs’ solu-
tion and in group 3 (n = 8) Krebs’ solution for dilution
combined with norepinephrine as an additive was used.
Physiological parameters (e.g. pH, pressure, flow) were
measured on-line. The viability of the intestine perfused
was tested by oxygen consumption and maltose absorp-
tion.
Materials and Method
Animals. The rat model was used in order to establish defined
strain combinations for transplantation experiments in the future.
Lewis rats served as blood donors for the ex vivo perfusion circuit
and also as organ donors. The animals were anesthetized with ether
followed by 0.05 mg/100 g body weight of 3.6% chloral hydrate,
injected intraperitoneally. The entire small bowel was harvested on
its vascular pedicle consisting of the arteria mesenterica superior and
vena portae, using the technique described by Monchik and Russel
[7]. The arteria mesenterica superior was cannulated with an Angio-
cath (Vialon-Angiocath, 20G Insyte-W, Becton Dickinson, Heidel-
berg, Germany). The venous outflow reached the blood reservoir
directly (fig. 1).
Experimental Groups. Three experimental groups were investi-
gated. In group 1 (n = 14) NaCl was used to dilute the blood to a
hematocrit of 30%. In group 2 (n = 11) Krebs’ solution and in group 3
(n = 8) Krebs’ solution and continuous administration of norepi-
nephrine as additive served for blood dilution. In each case, the
hematocrit was 30% and l-glutamine, as a substrate for the intestinal
epithelium, was instilled intraluminally.
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Perfusion System. The perfusion system consisted of a water bath
with a temperature kept continuously at 37°C by a thermostat
(Haake DC5, Haake, Karlsruhe, Germany), an oxygenator, a roller
pump (MCP, CA4, Ismatec, Wertheim, Germany), a pH meter (pH
540 GLP, WTW, Weilheim, Germany), a manometer (Direct BP 1,
Bilaney, Düsseldorf, Germany), an oxymeter (Oxi 538, WTW), and a
thermometer (INFCT, Newport Electronics, Deckenpfronn, Germa-
ny; fig. 1). The pressure during perfusion was kept at 100 mm Hg by
autoregulation of the computer system via the flow rate.
The oxygenator was constructed by ourselves and consisted of a
cylinder made of aluminum within a glass chamber. The aluminum
cylinder can be heated inside with water from the water bath. Tubes
consisting of a semipermeable membrane roll around the cylinder.
Gas (95% O2 and 5% CO2) is insufflated into the glass chamber.
Hemolysis due to the perfusion circuit was measured after each
experiment by analyzing free hemoglobin with a photometer. In
brief, serum was taken from the perfusion circuit after 1 and 2 h of
perfusion, serially diluted and the extinction was measured at 562
(A), 578 (C), 598 nm (B). Hemolysis was calculated as percentage of
free hemoglobin compared with the total hemoglobin.
Computer-Assisted Control System. The hardware used was a reg-
ular personal computer (Pentium I, 133 MHz, 1.2 GB hard disc,
24 MB RAM) with a screw-terminal board for signal wiring (PCL-
818L; Spectra, Leinfelden, Germany). The software consisted of
Windows 95 and a data acquisition software (Notebookpro version
9.02). With the program Build-Time, one can create a block diagram
of the experiment. With the so-called ICONview-Window, the set-
tings for each block are defined and connected with the block icons.
Via the connection of the block icons, a block diagram is created. By
connecting input block icons with the log block icon, data can be
recorded and through the display block icon they can be shown on-
line on the computer screen either as a graph or as a numeric value.
With the help of calculated block icons, data can be processed with a
variety of mathematical operations. Output signals are transformed
through output block icons.
Perfusion Solutions. Blood was harvested from Lewis rats via
puncture of the abdominal aorta. The syringe was flushed with hepa-
rin (100 U) before puncture. No further heparin was added to the
perfusion circuit. A hematocrit of 40–46% of the blood was diluted
with one of the three different perfusion solutions to a hematocrit of
30%. In group 1 0.9% NaCl with 24 mmol/l NaHCO3 was used, in
group 2 Krebs’ solution (140 mmol/l Na+, 4 mmol/l K+, 2.5 mmol/l
Ca2+, 1 mmol/l Mg2+, 106 mmol/l Cl–, 45 mmol/l lactate, 2 g/dl albu-
min 20%, 24 mmol/l NaHCO3 8.4%, 200 mg/dl dextrose, 7.3 mg/dl
taurocholic acid, 29.6 mg/dl MgSO4 and 13.6 mg/dl K3PO4) and in
group 3 Krebs’ solution and continuous infusion of norepinephrine
at a rate of 4–10 Ìg/h. The final volume of the perfusate was 18 ml
and the pH was adjusted to 7.40 by adding either NaHCO3 or CO2.
On-Line Measurements. pO2, pH, flow, pressure and temperature
were measured on-line via the computer system and recorded into an
Excel file.
Clinical Chemistry. Glucose, Na+, K+ and osmolarity were mea-
sured using standard laboratory methods.
Oxygen Consumption. Oxygen consumption was calculated every
30 min; starting 15 min after the beginning of perfusion, by drawing
blood from the perfusion system. Arterial blood was taken through a
line at the oxygenator outlet, venous blood was taken from the portal
outflow. Oxygen consumption was calculated using the following for-
mulas.
Oxygen consumption of the hemoglobin-bound oxygen was cal-
culated as follows.
£Hb = V˙ WHb WË WSSata – Satv
100
D W 100
w
where £Hb = oxygen consumption, hemoglobin (ml/min/100 g), V˙ =
flow (ml/min), Ë = Hüfner’s numbers 1.34 (ml O2/g Hb), Sata = arteri-
al oxygen saturation (%), Hb = hemoglobin (g/ml), Satv = venous oxy-
gen saturation (%) and w = organ weight (g).
The arterial oxygen pressure was kept at 200 mm Hg, therefore
the physically dissolved oxygen as part of the oxygen consumption
had to be calculated.
£Ph = V˙ W· W (pa – pv) W
100
w
where £Ph = oxygen consumption, physically (ml/min/100 g), · =
coefficient for oxygen in blood at 37°C: 2.813 W10–5 (ml O2/l Wmm
Hg), pa = arterial oxygen pressure (mm Hg) and pv = venous oxygen
pressure (mm Hg).
Final oxygen consumption:
£G = V˙ WFHb WË WSSata – Satv
100
D + · W (pa – pv)G W 100
w
where £G = oxygen consumption £Hb + £Ph (ml/min/100 g).
Maltose Absorption. 105 min after the start of the ex vivo perfu-
sion, maltose (0.5 mg/g body weight of the organ donor) was dis-
solved in 2.5 ml saline and instilled into the bowel. Blood was taken
before maltose instillation and 15 and 30 min thereafter. The glucose
concentration was measured using the hexokinase method. As a posi-
tive conctrol, maltose was instilled into the small bowel of an anes-
thetized Lewis rat (n = 4) in a concentration of 0.5 mg/g body weight.
The glucose concentration was measured before and 15 and 30 min
after maltose administration. As a negative control, the same maltose
test procedure was carried out after 45 min of warm ischemia (Arte-
ria mesenterica clamped in an anesthetized Lewis rat, n = 4).
Statistics. All results are calculated as means B SEM. Compari-
sons between the different groups were performed with one-way
analysis of variance and the pairwise multiple comparison procedure
(Student-Newman-Keuls method). Differences were considered sta-
tistically significant if p ! 0.05.
Results
In group 1 (perfusion solution diluted with NaCl), a
marked vasodilatation during the first 20–25 min was
registered. The blood pressure fell below the desired per-
fusion pressure of 100 mm Hg and could not be compen-
sated by an increased flow rate (fig. 2). About 10–15 min
after the start of perfusion, a hypersecretion into the bow-
el lumen and hypermotility started, which finally led to
the distension of the intestine. After 1 h, hyperemia and
an increase in the vascular resistance developed and the
flow rate fell below 1.5 ml/min. After instillation of malt-
ose into the bowel lumen, after 105 min of ex vivo perfu-
sion, no increase in the glucose concentration within the
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Fig. 2. Comparison of the flow rates of all
three groups. Flow rates are given as means
from all experiments performed in each
group. They were measured every 2 min (er-
ror bars were deleted for better illustration).
ANOVA and pairwise multiple comparison
procedures (Student-Newman-Keuls test)
were performed: p 1 0.05 (all groups,
30 min), p ! 0.05 (group 2 vs. group 1,
60 min) and p ! 0.05 (group 1 vs. group 2,
group 1 vs. group 3, and group 2 vs. group 3,
90 and 120 min).
Fig. 3. Oxygen consumption (groups 2, n =
11 and 3, n = 8).
perfusate could be detected. Also, no oxygen consumption
was registered. 2 h after the start of ex vivo perfusion, the
intestine showed no signs of viability. In group 2, the flow
rate increased steadily till the end of the experiment at
2 h (fig. 2), whereas blood pressure remained stable at
100 mm Hg. The increase in the flow rate was due to low
vascular resistance. If the experiment was continued for
more than 3 h, flow rate increased above 15 ml/min (data
not shown). During the entire perfusion procedure, oxy-
gen consumption was determined every 30 min. At every
time point, oxygen uptake was higher than 5 ml O2/min/
100 g, demonstrating a viable organ (fig. 3). At the end of
the perfusion procedure, a maltose absorption test was
performed. The increase in glucose concentration mea-
sured within the perfusate 15 and 30 min after instillation
of maltose into the bowel lumen did not differ from mea-
surements of rats in vivo (fig. 4, positive control), again
indicating viability of the intestine. In group 3, norepi-
nephrine was added to the Krebs’ solution initially, and
the concentration was kept at the basic value by contin-
uous infusion. The effect of norepinephrine was mainly a
marked reduction in hypersecretion and absence of low
vascular resistance at the end of the perfusion procedure
(fig. 2). The flow remained within the desired range of 4–
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Fig. 4. Maltose absorption (groups 2 and 3).
Fig. 5. Na+, K+, osmolarity at 0, 1 and 2 h (p 1 0.05), all three groups.
6 ml/min over the entire period (2 h). Oxygen consump-
tion and maltose absorption revealed a viable organ
(fig. 3, 4).
In comparison, the addition of norepinephrine to the
Krebs’ solution improved ex vivo perfusion significantly
(fig. 2). In all three groups, Na+, K+ and osmolarity did not
change significantly during perfusion (fig. 5). pH was kept
at 7.4 in all groups and the temperature remained stable at
37.6°C in all experiments. pO2 was 180–200 mm Hg in
each case and was adapted by changing the O2 insufflation
to the oxygenator. Glucose consumption was equal in
groups 2 and 3, but there was no glucose uptake in group 1
(fig. 6). During the 1st and 2nd h of ex vivo perfusion, a
significant amount of glucose was consumed by the small
bowel in groups 2 and 3 compared with group 1. Glucose
consumption in group 1 did not differ from perfusion of
blood through the perfusion system without an organ graft
(control; glucose consumption by the erythrocytes of the
perfusate, fig. 6), thus demonstrating viable organs in
groups 2 and 3, but not in group 1.
Hemolysis occurred during all perfusion experiments.
Due to extensive measurements of hemolysis after 2 h,
with and without a small bowel graft inserted into the per-
fusion circuit, we found that the main reason for hemoly-
sis was due to impaired erythrocytes at the connection
sites of the perfusion tubes. By improving this part of the
perfusion system, after 2 h of ex vivo small bowel perfu-
sion, free hemoglobin was reduced to 1.6% of the total
hemoglobin.
Discussion
Isolated ex vivo gut perfusion offers a variety of experi-
mental possibilities to study either ischemia/reperfusion
phenomena [8], or the potential role of local immunosup-
pression [3], as well as the ability of organ pretreatment to
reduce immunogenicity [9]. A large number of experi-
ments to study intestinal physiology was carried out in the
1960s to early 1980s. Most of the experimental protocols
used large animals such as dogs and cats [10–12]. When
the rat model was used, either in situ perfusion [13], xeno-
geneic blood cells as perfusate [3, 14], oxygenated buffer
solution as perfusate [15], or non-recirculating prepara-
tions [16] were used. The goal of our study was to establish
a perfusion model for intestinal perfusion that meets the
following requirements: (1) ex vivo perfusion in an organ
chamber, (2) recirculation of the perfusate, (3) normother-
mic perfusion, (4) syngeneic blood, including leukocytes
and lymphocytes as perfusate and (5) rat model.
5
4
Computer-Assisted ex vivo, Normothermic
Small Bowel Perfusion
Eur Surg Res 2000;32:100–106 105
Fig. 6. Glucose consumption (all three groups).
Despite the introduction of tacrolimus in the field of
small bowel transplantation, only little progress concern-
ing graft survival has been made throughout the last years
[1, 17]. The 3-year graft survival improved from 29% in
1996 to 38% at 3 years in 1997. These data are superior to
those of the cyclosporine era (11% at 3 years) but still far
behind the success rate of kidney or liver transplantation.
We therefore assume that further improvement will
only be achieved by applying new concepts in the field of
small bowel transplantation. A possibility is the pretreat-
ment of the graft to reduce its immunogenicity. Several
modalities are feasible: pretreatment with immunosup-
pressive agents (e.g. cyclosporine A and 15-deoxysper-
gualin) [3], pretreatment with monoclonal antibodies to
prevent lymphocyte-endothelial cell interaction [18] or
pretreatment with viral vectors for the expression of bio-
logically active molecules directly in the graft, to prevent
rejection [19], pretreatment to prevent ischemia-reperfu-
sion injury [20] and pretreatment to change the function
of endothelial cells [21].
Our model of ex vivo normothermic small-intestine
perfusion fulfills all of the prerequisites to study these new
concepts. We use an ex vivo model which mimics the clin-
ical situation, where a pretreatment of the donor, from an
ethical point of view, is not feasible. We use a recirculat-
ing perfusion chamber in order to achieve sufficient con-
tact between the graft and biologically active substances
during a 2-hour perfusion period. We have established a
normothermic perfusion circuit to enable biological reac-
tions to take place. Our perfusion solution consisted of
whole blood, which allows the investigation of leukocyte/
lymphocyte-endothelial cell interaction by means of in-
travital microscopy [22]. Finally, we have chosen the rat
model, which gives the opportunity to test pretreatment
protocols in a defined transplantation setup.
Windmueller et al. [6] described the problems in-
volved in small bowel perfusion.
(1) A hypersecretion into the bowel lumen that starts
only a few minutes after initiation of the ex vivo perfusion
circuit: this finally leads to a distention of the bowel with
decreased microvascular perfusion. We have observed the
same problem in group 1, where the perfusate was diluted
with NaCl.
(2) The hypermotility of the bowel, which was ascribed
to insufficient oxygenation [23], may in part be due to
intrinsic innervation: in our experiments, except for
group 1, hypermotility did not occur.
(3) Hyperemia at the beginning and low vascular resis-
tance at the end of the perfusion [6]: in their experiments,
Windmueller et al. [6] could solve these problems by add-
ing norepinephrine and dexamethasone to the perfusate.
Some of the side effects (e.g. low vascular resistance)
could be avoided by adding atropine. Before we started
the experiments in groups 2 and 3 we added atropine to
the protocol in group 1, but we were not successful in pre-
venting hypersecretion and low resistance (data not
shown). Dexamethasone as an additive to our perfusate
was avoided, because our model is supposed to be an
experimental model for the study of the interaction be-
tween leukocytes-lymphocytes and endothelial cells, a
phenomenon which is abrogated by the addition of gluco-
corticoids. In contrast to experiments described so far, we
have therefore used syngeneic whole blood, diluted to a
hematocrit of 30% with Krebs’ solution. Preparations
with washed xenogeneic erythrocytes [5], buffer solutions
alone [8], or nonrecirculating perfusion systems [16] are
easier to perform, but do not enable to study pretreatment
protocols or ischemia/reperfusion phenomena.
The major problems of ex vivo intestinal perfusion,
e.g. hypersecretion, hypermotility and hyperemia, are at
least in part due to the denervated small bowel prepara-
tion. Despite the existence of an autoregulation of intesti-
nal perfusion [24], loss of the effect of sympathetic post-
ganglionic vasoconstrictor fibers from the splanchnic
nerves leads to the above-described phenomena [25].
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Norepinephrinestimulates predominantly ·-adrenore-
ceptors and leads to constriction of the isolated perfused
mesenteric vasculature [26]. Thus, the addition of norepi-
nephrine to the Krebs’ solution was, in our experiments,
sufficient to prevent the major problems described for ex
vivo small bowel perfusion.
In ex vivo organ perfusion experiments, it is very
important to test the viability of the perfused organ. The
best way to test the viability of a perfused organ is, of
course, syngeneic transplantation after perfusion. How-
ever, this requires an extension of the experiments with
additional difficulties (e.g. microsurgery). Usually oxygen
consumption and glucose absorption serve as viability
parameters in small-intestinal preparations [5]. Oxygen
consumption in groups 2 and 3 showed sufficient uptake
to prove organ viability. The values measured are in good
agreement to previously published data [8, 13]. Maltose
absorption was used as an absorption test. It requires
intact enzymes of the mucosal brush border to beak down
maltose into fructose and glucose. An intact intestinal
brush border also indicates small bowel viability [16].
Glucose levels measured 15 and 30 min after intraluminal
administration of maltose agree with the results of Billiar
et al. [27] in small bowel isografts.
In summary, we have shown that ex vivo, normother-
mic, computer-assisted small bowel perfusion using whole
blood supplemented with Krebs’ solution and continuous
administration of norepinephrine as an additive enables
to study pretreatment protocols and ischemia/reperfusion
phenomena.
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